SciELO - Scientific Electronic Library Online

vol.19 número9Infecciones por Arcanobacterium haemolyticum: un patógeno emergente índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Anales de Medicina Interna

versión impresa ISSN 0212-7199


RUIZ GOMEZ, M. J.; SOUVIRON RODRIGUEZ, A.  y  MARTINEZ MORILLO, M.. P-glycoprotein, a membrane pump that represents a barrier to chemotherapy in cancer patients. An. Med. Interna (Madrid) [online]. 2002, vol.19, n.9, pp.49-57. ISSN 0212-7199.

Multidrug resistance (MDR) in oncology is considered to be the main cause of chemotherapy failure in the treatment of patients with cancer. The resistance mechanism consists in decrease intracellular drug accumulation by P-glycoprotein (Gp-P) overexpression. This protein acts as a drug-extracting pump that needs energy in the process. The efflux takes place by mean of a pore in the cell membrane that consist in twelve segments. The activity of this pump is regulated by protein kinase C and shows homology with other transport systems. The analysis of the presence of Gp-P and the characterization of MDR phenotype in biopsy material could be important in the overcome of the resistance to cancer chemotherapy.

Palabras clave : P-glycoprotein; Multidrug resistance; MDR; Oncology; Chemotherapy.

        · resumen en Español     · texto en Español     · Español ( pdf )


Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons